Article Information
History
- April 15, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nils C. Gassen1,$,
- Jan Papies2,3,
- Thomas Bajaj1,
- Frederik Dethloff4,
- Jackson Emanuel2,3,
- Katja Weckmann1,
- Daniel E. Heinz1,
- Nicolas Heinemann2,3,
- Martina Lennarz1,
- Anja Richter2,3,
- Daniela Niemeyer2,3,
- Victor M. Corman2,3,
- Patrick Giavalisco4,
- Christian Drosten2,3 and
- Marcel A. Müller2,3,5,$
- 1Department of Psychiatry and Psychotherapy, University of Bonn, 53127 Bonn, Germany
- 2Institute of Virology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany
- 3German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany
- 4Max Planck Institute for Aging, 50931 Cologne, Germany
- 5Martsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, Sechenov University, 119991 Moscow, Russia
- ↵$Contact: Correspondence should be addressed to Nils C. Gassen (nils.gassen{at}ukbonn.de) or Marcel A. Müller (marcel.mueller{at}charite.de)
Posted April 15, 2020.
Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics
